News for Hong Kong Exchanges and Clearing Limited (0388.HK)

Hong Kong's financial regulators have pledged to ease listing requirements for mainland Chinese companies, as they eye the city's stock market as a source of funding to support their global ambitions. Secretary for Financial Services and the Treasury Christopher Hui Ching-yu said on Thursday that the Securities and Futures Commission (SFC) and Hong Kong Exchanges and Clearing Limited (HKEX) were studying how to fine-tune existing listing rules. The market watchdog and the bourse operator would p

er the theme ‘Powering Connections’, according to a press release. The event will be held under …

Managers will be allowed to launch leveraged and inverse ETFs tracking single stocks overseas

Hong Kong's Advantages Spotlighted at WEF Annual Meeting in Davos

The London Metal Exchange (LME) on Monday added Hong Kong as one of its global warehouse locations to meet growing demand for the physical exchange of metals between mainland China and the rest of the world, while enhancing Hong Kong's role as a conduit.

This move aims to enhance the utility of RMB-denominated assets in global markets and promote the internationalization of the RMB. The announcement followed the approval of this initiative by the Securities and Futures Commission (SFC), the Hong Kong Monetary Authority (HKMA), and the People's Bank of China (PBOC).

Hong Kong Exchanges and Clearing Limited (HKEX) has announced two significant leadership appointments aimed at bolstering its strategic and operational capabilities.

SHANGHAI, Jan. 10, 2025 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy products, announced that the Center for Drug Evaluation (CDE) of the National Medical Products Administration of China (NMPA) granted Breakthrough Therapy Designation for Carteyva® (relmacabtagene autoleucel injection) as second-line treatment in adults with relapsed or refractory large B-cell lymphoma (r/r LBCL) . Carteyva® is an anti-CD19 autologous chimeric antigen receptor T (CAR-T) cell immunotherapy product independently developed by JW Therapeutics.

The latest listing reforms proposed by Hong Kong's bourse operator would help the city attract more initial public offerings (IPOs) and improve its chances of regaining bragging rights as the world's top venue for new share offerings, according to industry players. Hong Kong Exchanges and Clearing (HKEX) is seeking public feedback until March 19 on its plan to substantially reduce the public float requirement and increase the proportion of new shares for subscription by institutional investors.

Over the decades, stock exchanges have transformed from localized trading hubs into global financial powerhouses, influencing international capital flows and providing a lens into the economic prospects of their respective nations.

A lawmaker in Hong Kong is reportedly proposing adding Bitcoin (BTC) to the region's reserves for the purpose of financial stability.

After a satisfying year for investment bankers in Hong Kong, who helped lift the city back into the top 10 ranking in initial public offerings (IPOs) worldwide, the new year could be merrier as Hong Kong Exchanges and Clearing (HKEX) prepares for more market debutants. Companies and investors raised US$11 billion from 64 first-time stock offerings on the main board, according to data compiled by the London Stock Exchange Group, making it the fifth busiest IPO venue. India's two main exchanges an

The outlook for Hong Kong's initial public offering (IPO) market is expected to brighten next year on the back of lower interest rates and stronger regulatory support, according to deal makers. IPO volume in the city could rise by 70 per cent to HK$150 billion (US$19.3 billion), from HK$87.6 billion this year, according to a forecast by Deloitte, which has been collating the city's IPO data since 2011. Chinese companies' secondary listings will contribute a significant portion next year, buildin

The Hong Kong Exchanges and Clearing Limited (HKXCF) stock on the U.S. OTC market experienced a notable increase of 5.70%, trading at $39.34 per share with a vo

Hong Kong Exchanges and Clearing Limited (HKEX) has launched the HKEX Data Marketplace, a web-based platform that offers data users access to HKEX’s historical and reference data.

Offshore institutional investors in China’s bond market can now use China Government Bonds and Policy Bank Bonds held via Bond Connect as collateral for

The Hong Kong Exchanges and Clearing Limited (HKXCF) stock on the U.S. OTC market saw a significant increase of 12.34%, reaching $40.27 per share. The trading v

PR NewswireHONG KONG and SHANGHAI, Nov. 28, 2024 HONG KONG and SHANGHAI, Nov. 28, 2024 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. (he

Ping An Wins Sixth Director of the Year Award and Inaugural Climate Governance Award from the Hong Kong Institute of Directors